Anthem Biosciences IPO Allotment Check KFintech Status – Don’t Miss
Investors keenly await the Anthem Biosciences IPO allotment status, which was finalized on Thursday, July 17, 2025, through registrar KFin Technologies, following an overwhelming subscription.
New Delhi, India – July 17, 2025 – The highly anticipated Anthem Biosciences IPO allotment status has been finalized today, Thursday, July 17, 2025, much to the excitement of investors who eagerly participated in the public offering. The Bengaluru-based contract research, development, and manufacturing organization (CRDMO) witnessed an overwhelming response during its three-day bidding period, leading to a significant oversubscription of the issue.
Applicants can now check their IPO allotment status directly on the official website of the IPO registrar, KFin Technologies, or through the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) portals.
The initial public offering of Anthem Biosciences, which was entirely an Offer for Sale (OFS) amounting to ₹3,395 crore, opened for subscription on July 14, 2025, and concluded on July 16, 2025. This significant interest underscores the robust confidence investors hold in the pharmaceutical and biotech sectors, particularly in innovation-driven companies like Anthem Biosciences.
The company’s strong financial performance and its integral role in global drug discovery and development have been key drivers for this impressive demand.
Overwhelming Subscription and Investor Categories
The Anthem Biosciences IPO witnessed a remarkable overall subscription of 67.42 times, highlighting the intense investor appetite for this issue. Qualified Institutional Buyers (QIBs) led the charge with an astounding subscription rate of 192.80 times their allotted portion. Non-Institutional Investors (NIIs) also showed substantial interest, subscribing 44.70 times, while the retail individual investor (RII) portion was subscribed 5.98 times. Even the employee quota saw healthy demand, being subscribed nearly 7 times.
This broad-based participation from all investor categories reflects the widespread positive sentiment surrounding Anthem Biosciences’ business model and future growth prospects in the Contract Research and Manufacturing Services (CRAMS) space. The strong subscription figures often indicate a high likelihood of a positive listing, as investors are keen to gain exposure to the company’s shares.
Market experts have consistently emphasized the long-term growth potential of the CRDMO sector in India, making companies like Anthem Biosciences attractive investment opportunities. “The immense oversubscription of the Anthem Biosciences IPO is a clear indicator of the market’s confidence in India’s burgeoning biotech and pharma CRDMO capabilities,” stated Ms. Priya Sharma, a leading financial analyst based in Mumbai.
She further added, “Anthem Biosciences, with its comprehensive services and strong client base, is well-positioned to capitalize on the increasing outsourcing trends in global drug development. Investors are recognizing the intrinsic value and future earnings potential of such a specialized player.”
How to Check Your Anthem Biosciences IPO Allotment Status on KFintech
Checking your Anthem Biosciences IPO allotment status is a straightforward process, primarily facilitated by KFin Technologies, the official registrar for the IPO. Here’s a detailed guide on how to ascertain your allocation:
Step 1: Visit the KFintech Website
Navigate to the official KFin Technologies IPO allotment status page. You can often find this by searching “KFintech IPO allotment status” or directly accessing their portal at https://ris.kfintech.com/ipostatus/.
Step 2: Select the IPO
On the KFintech portal, you will find a dropdown menu labeled “Select IPO” or “Company Selection.” From this list, choose “Anthem Biosciences Ltd.” It is crucial to select the correct IPO name to retrieve accurate information.
Step 3: Choose Your Identification Method
KFin Technologies provides multiple options to check your allotment status. You can select one of the following:
- PAN Number: Enter your Permanent Account Number (PAN). This is often the most reliable and commonly used method.
- Application Number: Input the application number provided to you when you applied for the IPO.
- DP/Client ID: Enter your Depository Participant (DP) ID and Client ID. This is typically used for dematerialized accounts.
Step 4: Enter Details and Submit
Based on your chosen identification method, carefully enter the corresponding details in the designated field. After entering the information, complete any captcha verification required and then click on the “Submit” or “Search” button. Your Anthem Biosciences IPO allotment status will then be displayed on your screen.
Checking Allotment on BSE and NSE
In addition to KFin Technologies, investors can also verify their IPO allotment status on the websites of the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
For BSE:
- Visit the BSE IPO allotment status page:
- Under “Issue Type,” select “Equity.”
- From the “Issue Name” dropdown, choose “Anthem Biosciences Limited.”
- Enter your “Application Number” or “PAN.”
- Click on the “Search” button.
For NSE:
- Go to the NSE IPO bid details page:
- Select “Equity & SME IPO bid details.”
- Choose “Anthem Biosciences” from the list.
- Enter your PAN and Application Number.
- Click on “Submit.”
What Comes Next?
Following the finalization of the Anthem Biosciences IPO allotment status on July 17, 2025, the next crucial steps for investors involve the crediting of shares and potential refunds. Refunds for non-allotted shares are expected to be initiated on Friday, July 18, 2025. Simultaneously, shares will be credited to the demat accounts of successful allottees on the same day. The much-anticipated listing of Anthem Biosciences shares on both the NSE and BSE is tentatively scheduled for Monday, July 21, 2025.
Read more: Sabih Khan – The Unsung Genius Behind Apple Global Success
Market analysts are closely watching the grey market premium (GMP) for Anthem Biosciences, which has indicated a strong potential for listing gains, currently hovering around ₹150-₹157 over the issue price of ₹570 per share. This suggests an expected listing price in the range of ₹720-₹727, signaling a promising debut for the company.
Public Response and Market Outlook
The public response to the Anthem Biosciences IPO has been overwhelmingly positive, driven by the company’s strong fundamentals and the attractive prospects of the contract research and manufacturing sector.
Many retail investors and high-net-worth individuals expressed optimism about the company’s growth trajectory. “I applied for the Anthem Biosciences IPO because of their strong R&D focus and their presence in a high-growth sector. I am hopeful for a good listing,” said Mr. Suresh Kumar, a retail investor from Bengaluru, speaking on the eve of the allotment.
Anthem Biosciences, established in 2006, is recognized for its innovation-driven approach and fully integrated operations across drug discovery, development, and manufacturing for both small molecules and biologics. The company’s expertise in specialized fermentation-based Active Pharmaceutical Ingredients (APIs) has also contributed to its strong market position.
With a robust pipeline of active projects and an expanding global client base, Anthem Biosciences is poised for continued expansion and success in the pharmaceutical landscape. This strong foundation and promising outlook contribute significantly to the high demand seen for its public offering.
Frequently Asked Questions (FAQs) about Anthem Biosciences IPO Allotment Status
What is the Anthem Biosciences IPO allotment date?
The Anthem Biosciences IPO allotment date was finalized on Thursday, July 17, 2025.
Where can I check my Anthem Biosciences IPO allotment status?
You can check your Anthem Biosciences IPO allotment status on the official website of the IPO registrar, KFin Technologies , or on the websites of the BSE and NSE.
What details do I need to check my IPO allotment status on KFintech?
To check your IPO allotment status on KFintech, you will need either your PAN number, your IPO application number, or your DP/Client ID.
When will the shares be credited to my Demat account if I receive an allotment?
If you are successfully allotted shares in the Anthem Biosciences IPO, the shares are expected to be credited to your Demat account on Friday, July 18, 2025.
When is the Anthem Biosciences IPO listing date?
The shares of Anthem Biosciences are tentatively scheduled to be listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) on Monday, July 21, 2025.
What if I did not receive an allotment in the Anthem Biosciences IPO?
If you did not receive an allotment, the refund process for your application money is expected to begin on Friday, July 18, 2025.
What was the subscription rate for the Anthem Biosciences IPO?
The Anthem Biosciences IPO was subscribed an impressive 67.42 times overall, with significant demand from all investor categories.